Navigation Links
Visage Imaging Releases Amira 5.3
Date:7/19/2010

SAN DIEGO, Calif., July 19 /PRNewswire/ -- Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D and 4D biomedical data.

Amira's entirely new Neuro option contains a comprehensive set of tools for neuroscience research, specifically MR diffusion tensor imaging (DTI) as well as CT and MR brain perfusion imaging. The new option provides efficient calculation of perfusion results as well as analysis and display of multi-channel functional image data including gradients, tensors, and fiber tracking.

"With the new version of Amira, I finally get all the brain imaging tools I need, integrated in a single platform. The results from different modalities and functional calculations can be combined, processed, and presented together in very flexible ways – far superior to any other solution I know," says Prof. Dr. A. Brawanski, head of neurosurgery at the Regensburg University Hospital in Germany.

Furthermore, Amira 5.3 comes with a large number of new tools and improvements, such as DemoDirector, an easy-to-use graphical front end for creating animations and presentations using the popular DemoMaker module; a largely redesigned set of tools for spreadsheets and statistics; a number of enhancements to the popular FilamentEditor; and a full integration of the widely used Insight Segmentation and Registration Toolkit (ITK) into Amira's Developer Option.

"Amira 5.3 is the most powerful and reliable Amira ever – with hundreds of improvements and dozens of new modules and enhancements, designed in collaboration with leading research institutions all around the world. I am always impressed to see the level of activity and innovation in the ever-growing Amira community. Their contribution is what makes Amira so strong and so unique," says Dr. Hartmut Schirmacher, Director of Product Management for Visage Imaging.

Amira 5.3 is available for Windows 32 and 64 bit, Mac OS X, and Linux platforms. For more information, visit the product website www.amira.com.

Visage Imaging, Inc. – Visioneering Science for Life®

Visage Imaging is a global leading provider of scalable enterprise visualization, RIS and PACS solutions for clinical and preclinical imaging.  Targeted at hospitals and imaging centers of any size, the Visage products offer blazingly fast access to thin slice data anytime, anywhere, combined with a bi-directional RIS integration for a perfect workflow and a comprehensive set of clinical applications for all 2D, 3D and 4D interpretation and reporting, post-processing and image review tasks within and beyond radiology.  www.visageimaging.com

About Pro Medicus Limited

Pro Medicus Limited [ASX: PME] is Australia's leading medical IT and e-health provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. www.promedicus.com

Visage, Visage Imaging, and Visioneering Science for Life are registered trademarks of Pro Medicus Limited. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective holders.


'/>"/>
SOURCE Visage Imaging, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X
2. Visage Imaging Names John Danahy as General Manager North America, Sales and Services
3. Pro Medicus/Visage Imaging Signs Deal with Sydney-based Southern Radiology
4. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
5. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. Stereo Mammography Takes Breast Imaging to a New Dimension
8. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
9. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
10. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
11. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... YORK , Jan. 17, 2016  Attorney Advertising -- ... behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the ... to obtain additional information and assist the investigation by visiting ... concerns whether Anthera and certain of its officers and/or directors ... Act of 1934. ...
(Date:1/17/2017)... , Jan. 17, 2017  In a letter ... Jo Ann Jenkins outlines AARP,s priorities for ... Social Security, ensuring access to affordable health care coverage, ... In the letter Jenkins writes to President-elect Trump that ... Americans are counting on you to protect their Medicare ...
(Date:1/17/2017)... , Jan. 17, 2017 Immune Pharmaceuticals (NASDAQ: ... company, announced today that it will hold a Satellite Symposium ... Acute Leukemias (ISAL) XVI in Munich, Germany ... "Reinforcing the Efficacy of Immunotherapy for the maintenance of ... on Monday February 20 th , 2017 from 12:45 – ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s ... care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of ... according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD ...
(Date:1/17/2017)... NJ (PRWEB) , ... January 17, 2017 , ... Neil ... and financial planning assistance to communities throughout the region, is launching a charity drive ... Heart disease is by far the deadliest killer in America, and is responsible for ...
(Date:1/17/2017)... ... 2017 , ... Livionex, Inc., a Silicon Valley healthcare company focused on treating ... its dental gel that shows significant reduction in plaque levels and gum inflammation and ... was conducted at the Beckman Laser Institute at UC Irvine and has been published ...
(Date:1/17/2017)... ... 17, 2017 , ... The Sharie Withers Agency, a full-service ... latest beneficiary of their thriving community involvement program. The current campaign fundraises to ... dreams of terminally ill patients. Donations to this worthy cause may now be ...
(Date:1/17/2017)... ... 17, 2017 , ... Today, FloSports , a global leader in live ... as part of a long-term extension of their media partnership. The partnership, which began ... of the sport’s premier events exclusively on FloWrestling.com as well as usage of the ...
Breaking Medicine News(10 mins):